Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders.

about

Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders.

Item

http://www.wikidata.org/entity/Q36928725

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Allogeneic hematopoietic stem ...... lymphoproliferative disorders.

@en

type

Item

label

Allogeneic hematopoietic stem ...... lymphoproliferative disorders.

@en

prefLabel

Allogeneic hematopoietic stem ...... lymphoproliferative disorders.

@en

P1476

Allogeneic hematopoietic stem ...... lymphoproliferative disorders.

@en

P2093

Ana Marcela Rojas Fonseca-Hial

http://www.w3.org/2001/XMLSchema#string

Jose Salvador Rodrigues Oliveira

http://www.w3.org/2001/XMLSchema#string

Katya Parisio

http://www.w3.org/2001/XMLSchema#string

P2860

The evolving role of stem cell transplants in lymphomas

Hematopoietic SCT in Europe: data and trends in 2011.

Barriers to the Access and Use of Rituximab in Patients with Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: A Physician Survey.

Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.

Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies

Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomes.

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.

Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.

P304

99-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BJHH.2016.02.006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27208567

http://www.w3.org/2001/XMLSchema#string

P932

4877659

http://www.w3.org/2001/XMLSchema#string